Symbiotec Pharmalab Shares Set for Market Debut
· Business · Economic Times, LiveMint, Business Standard
Shares of Symbiotec Pharmalab are scheduled to list on the BSE and NSE on Tuesday following an IPO priced at Rs 988 per share. The company's grey market premium currently signals a potential 19% listing gain for investors. The Rs 1,757 crore public issue was subscribed 75.08 times, with strong interest from qualified institutional buyers. Proceeds from the fresh issue will be used to prepay or repay outstanding borrowings.
Why it matters
The listing is a significant event for investors who participated in the highly subscribed IPO and are looking for short-term gains.
Read the original report — Economic Times
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.